Literature DB >> 8428915

The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.

J A Hamilton1, L K Steinrauf, B C Braden, J Liepnieks, M D Benson, G Holmgren, O Sandgren, L Steen.   

Abstract

The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-A resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (Fobs > 2.0 sigma). Standard deviations for stereochemical parameters are 0.018 and 0.022 A for bond distances, 0.030 and 0.038 A for angle distances, and 0.035 and 0.070 A for planar 1-4 distances. The newly refined normal structure shows improvement over the original structure of Blake and Swan (Blake, C. C. F., and Swan, I. D. A. (1971) J. Mol. Biol. 61, 217-224) in stereochemistry and in the conformation of the loop regions. Residues Arg-103, Thr-123, Asn-124, and Pro-125 have now been resolved, and residues 1-9 and 126-127 have been modeled with the aid of simulated annealing refinement. The functional form of transthyretin is a tetramer, having a cylindrical cavity which will bind thyroxine and an exterior binding site for the complex of retinol with retinol-binding protein. The monomer is a beta barrel flattened to become more like a sandwich with residue 30 in the interior. The methionyl for valyl substitution forces the beta sheets of the monomer as much as 1 A apart, resulting in a distortion of the thyroxine-binding cavity, in agreement with the independent observations that the Met-30 variant has low affinity for thyroxine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Deciphering common failures in molecular docking of ligand-protein complexes.

Authors:  G M Verkhivker; D Bouzida; D K Gehlhaar; P A Rejto; S Arthurs; A B Colson; S T Freer; V Larson; B A Luty; T Marrone; P W Rose
Journal:  J Comput Aided Mol Des       Date:  2000-11       Impact factor: 3.686

2.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

3.  Beta-helix core packing within the triple-stranded oligomerization domain of the P22 tailspike.

Authors:  J F Kreisberg; S D Betts; J King
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

4.  Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation.

Authors:  Jane S Richardson; David C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

5.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

6.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

7.  Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.

Authors:  Roger S Armen; Mari L DeMarco; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

8.  A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis.

Authors:  D E Jenne; K Denzel; P Blätzinger; P Winter; B Obermaier; R P Linke; K Altland
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

9.  Heating of proteins as a means of improving crystallization: a successful case study on a highly amyloidogenic triple mutant of human transthyretin.

Authors:  Anders Karlsson; A Elisabeth Sauer-Eriksson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-21

10.  Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases.

Authors:  Roger S Armen; Brady M Bernard; Ryan Day; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.